journal article·2023-03-24Open access

Magnetic Nanoscalpel for the Effective Treatment of Ascites Tumors

Tatiana Zamay, Sergey Zamay, Natalia Luzan, Victoriya Fedotovskaya, Albert Masyugin, Fyodor Zelenov, Anastasia Koshmanova, Elena Nikolaeva, Daria Kirichenko, Dmitry Veprintsev, Olga Kolovskaya, Irina Shchugoreva, Galina Zamay, Ivan Lapin, Anna Lukyanenko, Andrey Borus, Alexander Sukhachev, Mikhail Volochaev, Kirill Lukyanenko, Alexandr Shabanov, Vladimir Zabluda, Alexey Zhizhchenko, Aleksandr Kuchmizhak, Alexey Sokolov, Andrey Narodov, Vladimir Prokopenko, Rinat Galeev, Valery Svetlichnyi, Anna Kichkailo

Abstract

One of the promising novel methods for radical tumor resection at a single-cell level is magneto-mechanical microsurgery (MMM) with magnetic nano- or microdisks modified with cancer-recognizing molecules. A low-frequency alternating magnetic field (AMF) remotely drives and controls the procedure. Here, we present characterization and application of magnetic nanodisks (MNDs) as a surgical instrument (“smart nanoscalpel”) at a single-cell level. MNDs with a quasi-dipole three-layer structure (Au/Ni/Au) and DNA aptamer AS42 (AS42-MNDs) on the surface converted magnetic moment into mechanical and destroyed tumor cells. The effectiveness of MMM was analyzed on Ehrlich ascites carcinoma (EAC) cells in vitro and in vivo using sine and square-shaped AMF with frequencies from 1 to 50 Hz with 0.1 to 1 duty-cycle parameters. MMM with the “Nanoscalpel” in a sine-shaped 20 Hz AMF, a rectangular-shaped 10 Hz AMF, and a 0.5 duty cycle was the most effective. A sine-shaped field caused apoptosis, whereas a rectangular-shaped field caused necrosis. Four sessions of MMM with AS42-MNDs significantly reduced the number of cells in the tumor. In contrast, ascites tumors continued to grow in groups of mice and mice treated with MNDs with nonspecific oligonucleotide NO-MND. Thus, applying a “smart nanoscalpel” is practical for the microsurgery of malignant neoplasms.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Microfluidic and Bio-sensing Technologies · Nanoparticle-Based Drug Delivery · Characterization and Applications of Magnetic Nanoparticles

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Federal Research Center “Krasnoyarsk Science Center” of the Siberian Branch, Russian Academy of Sciences, Krasnoyarsk 660036, Russia

Laboratory for Biomolecular and Medical Technologies, Prof. V.F. Voino-Yasenetsky Krasnoyarsk State Medical University, Krasnoyarsk 660022, Russia

JSC «NPP «Radiosviaz», Krasnoyarsk 660021, Russia

Laboratory of Advanced Materials and Technology, Siberian Physical Technical Institute, Tomsk State University, Tomsk 634050, Russia

L.V. Kirensky Institute of Physics, Siberian Branch of the Russian Academy of Sciences, Krasnoyarsk 660036, Russia

Institute of Automation and Control Processes (IACP), Far Eastern Branch of the Russian Academy of Science, Vladivostok 690041, Russia

Far Eastern Federal University, Vladivostok 690950, Russia

V.P. Astafiev Krasnoyarsk State Pedagogical University, Krasnoyarsk 660049, Russia

Funding

Krasnoyarsk Regional Fund for Support of Scientific and Scientific and Technical Activities

References (36)

Show source-provided references
1. Cancer incidence and mortality patterns in Europe: Estimates for 40 countries and 25 major cancers in 201810.1016/j.ejca.2018.07.005 ↗
2. Cancer statistics, 201910.3322/caac.21551 ↗
3. Cancer statistics, 202010.3322/caac.21590 ↗
4. Cancer statistics, 202210.3322/caac.21708 ↗
5. Lisio, M.A., Fu, L., Goyeneche, A., Gao, Z.H., and Telleria, C. (2019). High-grade serous ovarian cancer: Basic sciences, clinical and therapeutic standpoints. Int. J. Mol. Sci., 20.10.3390/ijms20040952 ↗
6. Impact of ascites volume on clinical outcomes in ovarian cancer: A cohort study10.1016/j.ygyno.2017.06.008 ↗
7. Almeida-Nunes, D.L., Mendes-Frias, A., Silvestre, R., Dinis-Oliveira, R., and Ricardo, S. (2022). Immune Tumor Microenvironment in Ovarian Cancer Ascites. Int. J. Mol. Sci., 23.10.3390/ijms231810692 ↗
8. Malignant ascites: A review of prognostic factors, pathophysiology, and therapeutic measures10.4240/wjgs.v4.i4.87 ↗
9. Cancer treatment by magneto-mechanical effect of particles, a review10.1039/D0NA00187B ↗
10. Versatile magnetic microdiscs for the radio enhancement and mechanical disruption of glioblastoma cancer cells10.1039/D0RA00164C ↗
11. Magnetic Nanoparticles for Medical Applications: Updated Review
12. Magnetic particles with perpendicular anisotropy for mechanical cancer cell destruction10.1038/s41598-017-04154-1 ↗
13. Magneto-actuated cell apoptosis by biaxial pulsed magnetic field10.1038/s41598-017-11279-w ↗
14. Uniform and water stable magnetite nanoparticles with diameters around the monodomain–multidomain limit10.1088/0022-3727/41/13/134003 ↗
15. Saturation Magnetization of Ferromagnetic and Ferromagnetic Nanocrystals at Room Temperature10.1088/0022-3727/40/2/006 ↗
16. Cullity, B.D. (1972). Addison-Wesley Pub. Co.
17. Magnetic nanoparticles: Synthesis, protection, functionalization, and application10.1002/anie.200602866 ↗
18. Current challenges in cancer treatment10.1016/j.clinthera.2016.03.026 ↗
19. Biofunctionalized magnetic-vortex microdiscs for targeted cancer-cell destruction10.1038/nmat2591 ↗
20. Aptamers: A promising chemical antibody for cancer therapy10.18632/oncotarget.7178 ↗
21. Fu, Z., and Xiang, J. (2020). Aptamers, the Nucleic Acid Antibodies, in Cancer Therapy. Int. J. Mol. Sci., 21.10.3390/ijms21082793 ↗
22. Analysis of aptamer discovery and technology10.1038/s41570-017-0076 ↗
23. In vitro selection of RNA molecules that bind specific ligands10.1038/346818a0 ↗
24. Aljohani, M.M., Cialla-May, D., Popp, J., Chinnappan, R., Al-Kattan, K., and Zourob, M. (2022). Aptamers: Potential Diagnostic and Therapeutic Agents for Blood Diseases. Molecules, 27.10.3390/molecules27020383 ↗
25. Basu, D., Chakraborty, S., Pal, R., Sharma, T.K., and Sarkar, S. (2021). Identification and Engineering of Aptamers for Theranostic Application in Human Health and Disorders. Int. J. Mol. Sci., 22.10.3390/ijms22189661 ↗
26. Noninvasive Microsurgery Using Aptamer-Functionalized Magnetic Microdiscs for Tumor Cell Eradication10.1089/nat.2016.0634 ↗
27. DNA-aptamer/protein interaction as a cause of apoptosis and arrest of proliferation in Ehrlich ascites adenocarcinoma cells10.1134/S1990747813050061 ↗
28. Kolovskaya, O.S., Zamay, T.N., Zamay, G.S., Babkin, V.A., Medvedeva, E.N., Neverova, N.A., Kirichenko, A.K., Zamay, S.S., Lapin, I.N., and Morozov, E.V. (2020). Aptamer-Conjugated Superparamagnetic Ferroarabinogalactan Nanoparticles for Targeted Magnetodinamic Therapy of Cancer. Cancers, 12.10.3390/cancers12010216 ↗
29. Nucleic Acid Aptamers Increase the Anticancer Efficiency and Reduce the Toxicity of Cisplatin-Arabinogalactan Conjugates in Vivo10.1089/nat.2022.0024 ↗
30. On-demand concentration of an analyte on laser-printed polytetrafluoroethylene10.1039/C8NR06119J ↗
31. Development of SEM method for analysis of organ-containing objects using inverse opals
32. Equilibrium large vortex state in ferromagnetic disks10.1063/1.4809760 ↗
33. Analysis of nanoparticle delivery to tumours10.1038/natrevmats.2016.14 ↗
34. Size and shape effects in the biodistribution of intravascularly injected particles10.1016/j.jconrel.2009.10.014 ↗
35. Apoptosis: A review of programmed cell death10.1080/01926230701320337 ↗
36. Disk-shaped magnetic particles for cancer therapy10.1063/1.5123716 ↗